Many thanks for helpful comments
I don't see a way to edit here, so a correction: the target range for afib seems to be 2-3, while the INR target after valve replacement is something different, and to 2-4 for other settings (like after orthopedic surgery).
Hi. I know that in clinical trials, bleeding in the eye is counted as "major" bleeding. But are you talking about within the eye or on the surface?
The target range for INR is usually 2-4. You might keep your INR in range with strict attention to foods that affect it.
The new oral anticoagulants that are most advanced in development are dabigatran and rivaroxaban. They require no monitoring. There's also a once per week injectable: biotinylated idraparinux.
My mom got eye bleeds from Plavix as well. The doctor said that it was not a serious side effect. So people may just be prone to them.